Clinical significance of antibodies against oxidised low density lipoprotein in early RA.
AUTOR(ES)
Paimela, L
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1010238Documentos Relacionados
- Role of oxidised low density lipoprotein in atherogenesis
- Diagnostic role of antikeratin antibodies in RA.
- Oxidised low density lipoproteins and atherogenesis.
- Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis.
- Sulphasalazine therapy in RA.